This page is an English translation of the Korean original. If there is any discrepancy, the Korean version prevails.
| Item | Details |
|---|---|
| A. Classification codes | ICD-10: Q20.5 | Special Copayment Reduction: V144 (rare disease Special Copayment Reduction) |
| B. Synonyms | Corrected transposition, Discordant Atrioventricular Connection, L-Transposition, Ventricular Inversion |
| C. Adult onset | Likelihood of first onset in adulthood moderate to high — in the simple form without associated anomalies (isolated ccTGA), there are not a few cases in which patients remain asymptomatic for decades and are first diagnosed in their 30s–50s, when atrioventricular block, tricuspid regurgitation, and systemic right ventricular failure worsen. The cumulative risk of complete atrioventricular block is about 2% per year, so it must be included in the differential diagnosis when first symptoms (syncope, bradycardia) are found in adulthood. |
| 1. History | 1957: systematic classification by Van Praagh → 1963: first report of surgical correction → 1980s: concept of anatomic repair (double switch operation) established → 2000s: long-term follow-up of atrial switch and Fontan procedures → emergence of systemic right ventricular failure in adulthood as an issue. |
| 2. Causes | Abnormal rotation of the great arteries at 4–5 weeks of embryonic development: reversal of the direction of cardiac looping (L-loop), reversal of aortic and pulmonary artery connections. Multifactorial factors predominate over single-gene mutations. Abnormalities of the ZIC3, CITED2, LEFTYA/B, and NODAL pathways. |
| 3. Genetics | Mostly sporadic. ZIC3 variants (X-linked) are associated with left-right asymmetry abnormalities. Heterozygous LEFTYA/B, NODAL, CFC1, and ACVR2B variants reported. With accompanying situs inversus, review Primary Ciliary Dyskinesia (PCD)-related genes. |
| 4. General epidemiology | Accounts for about 0.5–1% of congenital heart disease. About 2 per 10,000 live births. Similar male-to-female ratio. Korean rare disease registration: Q20.5, Special Copayment Reduction V144. Relatively high proportion diagnosed in adulthood (decades without symptoms possible in mild phenotypes). |
| 5. Pathophysiology | Double discordance: atrioventricular discordance + ventriculoarterial discordance, so blood flow is physiologically maintained. However, the systemic ventricle is a morphologic right ventricle (RV), which is exposed long-term to high systemic pressure, leading to reduced systolic function and worsening tricuspid regurgitation. |
| 6. Symptoms | Simple form: asymptomatic for decades. Cyanosis, heart failure, and tachycardia appear depending on associated anomalies (VSD, PS, tricuspid regurgitation). First symptoms in adulthood: exercise intolerance, dyspnea, fatigue, atrial fibrillation, complete atrioventricular block (cumulative risk in 30s–50s ~2%/year). |
| 7. Signs | Aortic pulsation palpable at the lower left sternal border. In the simple form, auscultation is normal or there is a systolic murmur of VSD. ECG: left-sided conduction abnormalities, first-degree atrioventricular block, complete left or right bundle branch block. Chest X-ray: straightening of the upper left border (position of the morphologic aorta). |
| 8. Screening | Before birth: fetal echocardiography (18–22 weeks of pregnancy). Newborns: oxygen saturation screening (CCHD screening). Adulthood: incidentally found ECG abnormalities, atrioventricular block, abnormal chest X-ray findings → echocardiography. |
| 9. Diagnosis | Echocardiography: atrial, ventricular, and great artery connections and morphological identification. Cardiac MRI: quantification of ventricular volume, function, and fibrosis. Cardiac catheterization: pressure measurement, confirmation of anatomy by angiography. Electrophysiological study: evaluation of atrioventricular block and accessory pathways. |
| 10. Treatment | Correction of associated anomalies (VSD patch, relief of PS). Systemic RV failure: ACE inhibitors, beta-blockers. Anatomic repair (double switch operation: arterial switch + atrial switch) applied selectively in childhood. Complete atrioventricular block: permanent pacemaker. End stage: heart transplantation. |
| 11. Prognosis | 20-year survival in the simple form about 80% or more. Systemic RV failure and tricuspid regurgitation are the main long-term complications. Risk of complete atrioventricular block ~2%/year (cumulative). Early detection of declining ventricular function through regular follow-up (cardiac MRI, Holter, BNP) is key. |
| 12. Prevention | Early prenatal diagnosis by fetal echocardiography. Adult follow-up: annual visits to a specialized adult congenital heart disease (ACHD) center. Activity guidelines after pacemaker implantation. Multidisciplinary counseling mandatory for pregnancy. |
| 13. References | Warnes CA et al. JACC 2008; Graham TP et al. JACC 2008 … and 8 other papers |
Congenitally corrected transposition of the great arteries (ccTGA) is a rare congenital heart disease in which atrioventricular discordance and ventriculoarterial discordance coexist, and because of the unique structural feature of 'double discordance', it is partially compensated hemodynamically. Understanding of this disease advanced in earnest as classification systems for congenital heart disease developed in the mid-20th century.
In 1957, Richard Van Praagh proposed segmental analysis of the heart, establishing a framework that systematically classifies complex congenital heart disease by three elements: atrial situs, direction of ventricular looping (D/L-loop), and great artery connection (transposition/normal). According to this, ccTGA corresponds to the {S,L,L} or {I,D,D} variants, arising from a combination of L-looping and L-transposition in atrial situs solitus or inversus. This system provided an essential conceptual framework for clearly distinguishing corrected transposition of the great arteries from complete transposition of the great arteries (D-TGA) and for planning surgical approaches.
Clinically, ccTGA was first described in detail in the 1950s–60s. The first surgical correction was attempted in 1963, and the main approach was surgery to correct the associated ventricular septal defect and pulmonary stenosis. However, simple anatomical correction alone could not solve the fundamental problem that the morphologic right ventricle must continue to function as the systemic ventricle.
From the 1980s, the concept of 'anatomic repair' emerged to solve this problem. The double switch operation, in which an atrial switch (Senning or Mustard operation) and an arterial switch are performed simultaneously, was proposed, and its use in selected pediatric patients has been reported since the 1990s. The goal of this operation is to reconstruct the heart so that the morphologic left ventricle supports the systemic circulation, preventing long-term ventricular dysfunction.
Since the 2000s, long-term follow-up studies have made clear that the cumulative occurrence of systemic right ventricular failure, tricuspid regurgitation, and complete atrioventricular block are important clinical issues in adult patients with corrected transposition of the great arteries. With the establishment of adult congenital heart disease (ACHD) care systems, transition management of ccTGA patients into adulthood has been emphasized, and multidisciplinary approaches such as quantification of right ventricular function with cardiac MRI, electrophysiological surveillance, and cardiac resynchronization therapy (CRT) form the core of modern treatment. In Korea, long-term follow-up programs for this disease are operated centered on the congenital heart disease society and specialized adult congenital heart disease centers.
The cause of corrected transposition of the great arteries is explained as an abnormality in the direction of ventricular looping occurring early in embryonic heart development (about 4–5 weeks after fertilization). Normally, the primitive cardiac tube develops through rightward D-looping so that the morphologic right ventricle lies on the right and the left ventricle on the left. In ccTGA, L-looping occurs, so the morphologic right ventricle lies on the left and the left ventricle on the right.
This reversal of the direction of ventricular looping results in atrioventricular discordance. That is, the right atrium connects to the morphologic left ventricle, and the left atrium connects to the morphologic right ventricle. In addition, the great artery connections are also reversed (ventriculoarterial discordance), so the morphologic left ventricle connects to the pulmonary artery and the morphologic right ventricle to the aorta. Because these two discordances coexist, the direction of blood circulation is physiologically maintained—venous blood flows in the order right atrium → left ventricle (morphologic) → pulmonary artery → lungs → left atrium → right ventricle (morphologic) → aorta.
In terms of genetic causes, ccTGA mostly occurs sporadically, and cases with a clearly identified single-gene cause are rare. However, variants in genes involved in the left-right patterning pathway have been reported. The ZIC3 gene is located on the short arm of the X chromosome and is involved in cardiac looping and determination of left-right asymmetry. Pathogenic ZIC3 variants can cause complex congenital heart disease with X-linked situs inversus in heterozygous women. Cases have also been reported in which heterozygous variants in components of the NODAL signaling pathway (NODAL, LEFTY1/2, CFC1, ACVR2B, etc.) are associated with sporadic ccTGA or heterotaxy-related cardiac malformations.
About 5–8% of ccTGA patients have accompanying situs inversus totalis or heterotaxy. When heterotaxy is present, variants in Primary Ciliary Dyskinesia (PCD)-related genes (DNAI1, DNAI2, DNAH5, DNAH11, etc.) may be the cause, so appropriate gene panel testing is recommended. As environmental factors, diabetes in early pregnancy, certain drugs (retinoids, etc.), and viral infections have been proposed as general risk factors for congenital heart disease, but no environmental cause specific to ccTGA has been established. Most ccTGA is understood to arise through a multifactorial mechanism.
The genetics of corrected transposition of the great arteries mostly show a sporadic pattern, and the familial recurrence rate is reported to be similar to that of congenital heart disease in general (sibling recurrence rate about 1–3%). Cases in which a specific single-gene variant has been established as the main cause of ccTGA are rare, and no specific causative gene is identified in most patients.
However, gene variants in signaling pathways involved in cardiac looping and determination of left-right asymmetry are attracting attention as causes of ccTGA and related complex congenital heart disease. ZIC3 (Zinc finger protein of the cerebellum 3, Xq26.3) is a regulator of left-right asymmetry signaling in early embryonic development, and variants associated with X-linked heterotaxy and cardiac malformations have been reported. Women carrying such variants may be asymptomatic carriers, but in men the variants present as complex congenital heart disease.
Common associated anomalies in ccTGA include ventricular septal defect (VSD, about 60–80%), pulmonary stenosis (PS, about 40–50%), malformation of the tricuspid valve (the morphologic systemic atrioventricular valve) (about 30–40%), and atrioventricular conduction abnormalities. Anatomically abnormal placement of the atrioventricular node (AV node) and His bundle is inherent to this disease, providing a structural basis that makes congenital atrioventricular conduction abnormalities likely. Unlike normal, the atrioventricular node is often located anteriorly, and the His bundle runs along an unusual path, so it can easily be damaged during surgical manipulation.
Regarding association with chromosomal abnormalities, unlike simple D-TGA, ccTGA has a relatively low association with major chromosomal syndromes such as 22q11.2 deletion (DiGeorge syndrome), but when heterotaxy is present, chromosomal microdeletion testing is considered. Gene panel testing (including genes related to complex congenital heart disease) is recommended when situs inversus or heterotaxy is present, when there is a family history, or when there are multiple anomalies. De novo pathogenic variants have also been reported in ccTGA cases, and next-generation sequencing (NGS)-based whole exome or whole genome analysis is used to identify the genetic causes of complex congenital heart disease of unknown cause. In genetic counseling, a comprehensive explanation of recurrence risk, family testing, and the possibility of associated anomalies is needed.
Corrected transposition of the great arteries is a rare disease accounting for about 0.5–1% of all congenital heart disease and is estimated to occur in about 1 in 5,000–10,000 live births, although reports differ somewhat between institutions. In large registry studies published internationally, a proportion of 0.5–0.7% of all congenital heart disease is most often cited. There is no clear difference in occurrence by sex, but some studies have observed a slightly higher frequency in males.
In Korea, patients classified under code Q20.5 are managed through Health Insurance Review & Assessment Service (HIRA) and congenital heart disease registry data, and upon registration under Special Copayment Reduction code V144 they can receive rare disease medical cost support. In a Korean single-center congenital heart disease cohort study, ccTGA was reported to account for about 0.7–1.2% of all congenital heart disease. ccTGA is divided into a simple form without associated anomalies (isolated ccTGA) and a complex form with associated anomalies; in the simple form, there are not a few cases discovered incidentally in adulthood or first diagnosed in adulthood with mild symptoms.
The proportion diagnosed in adulthood is relatively high compared with other cyanotic congenital heart diseases, with 10–20% of all patients first diagnosed in adulthood (after age 18) in some cohorts. This is because the simple form of ccTGA remains asymptomatic for decades and symptoms appear as atrioventricular block, ventricular dysfunction, or tricuspid regurgitation worsens. Therefore, it is important to include ccTGA in the differential diagnosis of patients with unexplained atrioventricular block or heart failure in adult cardiology clinics.
The incidence of complete atrioventricular block in ccTGA patients is reported at about 2% per year, so 20 years after diagnosis about 30–40% of patients require a permanent pacemaker. When VSD and PS are present, surgical correction is performed in childhood, but even after corrective surgery, progression of systemic right ventricular dysfunction and tricuspid regurgitation remains the main long-term challenge. Because of the rarity and complexity of this disease, intensive management at an experienced ACHD center is recommended.
The core pathophysiology of corrected transposition of the great arteries stems from double discordance. In the normal heart, the connections are right atrium → right ventricle (morphologic) → pulmonary artery, and left atrium → left ventricle (morphologic) → aorta. In ccTGA, two reversals occur simultaneously: ① atrioventricular discordance (right atrium → morphologic left ventricle, left atrium → morphologic right ventricle), and ② ventriculoarterial discordance (morphologic left ventricle → pulmonary artery, morphologic right ventricle → aorta). These two discordances cancel out, so venous blood is delivered correctly to the lungs and arterial blood to the systemic circulation. For this reason it was given the name 'physiologically corrected'.
However, there is a fundamental problem with this structure: the morphologic right ventricle becomes the ventricle supporting the systemic circulation. The morphologic right ventricle is originally designed to support the low-pressure pulmonary circulation and, unlike the left ventricle with its thick spiral muscle fiber structure, is vulnerable to pressure load. A morphologic right ventricle continuously exposed to the high systemic afterload progresses over time to ventricular hypertrophy, ventricular dilation, and reduced systolic function. This process progresses slowly over decades but worsens much faster when there are associated anomalies or tricuspid regurgitation.
The tricuspid valve (the atrioventricular valve of the morphologic right ventricle) is continuously exposed to systemic pressure, and as the ventricle dilates, the valve annulus stretches and functional tricuspid regurgitation progresses. Tricuspid regurgitation aggravates volume overload of the morphologic right ventricle, which in turn worsens ventricular dilation and regurgitation, forming a vicious cycle. Ultimately, systemic right ventricular failure becomes the most important long-term complication of ccTGA.
Abnormal placement of the atrioventricular conduction system is also an important pathogenic feature of ccTGA. The normal atrioventricular node lies within the triangle of Koch, but in ccTGA the atrioventricular node is in an abnormal anterior position and the His bundle runs along an unusual path (anterior His bundle). This abnormal conduction pathway is the basis for congenital first- and second-degree atrioventricular block and tends to progress to complete atrioventricular block over time. The risk of damaging this abnormal conduction system during corrective surgery is also high. In addition, accessory pathways may accompany it and cause tachyarrhythmias such as WPW syndrome.
The clinical symptoms of corrected transposition of the great arteries vary greatly depending on the presence of associated anomalies, ventricular function, the degree of tricuspid regurgitation, and the presence of atrioventricular conduction abnormalities. The simple form without associated anomalies (isolated ccTGA) may be completely asymptomatic for decades and is sometimes diagnosed incidentally after adulthood.
Symptoms in childhood: when an associated ventricular septal defect (VSD) is large, heart failure symptoms due to left-to-right shunting (tachypnea, feeding difficulty, sweating, failure to thrive) appear from infancy. When associated pulmonary stenosis (PS) is present, cyanosis may develop, and when VSD and PS coexist, the clinical picture resembles tetralogy of Fallot. With a large VSD without severe PS, there is initially increased pulmonary blood flow due to left-to-right shunting, but over time pulmonary hypertension progresses and Eisenmenger physiology may develop.
Symptoms in adulthood: in patients with the simple form or who did not undergo complete correction in childhood, the following symptoms appear in adulthood (30s–50s). First, exertional intolerance and dyspnea: these occur because, as systolic function of the morphologic right ventricle slowly declines, cardiac output cannot be increased sufficiently during exercise. Second, fatigue: this stems from a chronic low cardiac output state. Third, arrhythmia symptoms: atrial fibrillation, atrial flutter, and bradycardia or syncope due to complete atrioventricular block may occur. Complete atrioventricular block accumulates at a risk of about 2% per year and causes sudden dizziness or syncope. Fourth, chest pain: may appear due to relative ischemia from ventricular hypertrophy or with associated coronary artery anomalies.
Symptoms related to atrioventricular conduction abnormalities: first-degree atrioventricular block is asymptomatic, but with progression to high-grade atrioventricular block, bradycardia, dizziness, pre-syncope, and syncope occur. When complete atrioventricular block occurs, loss of consciousness may appear as Stokes-Adams attacks, and immediate permanent pacemaker implantation is required. In some, tachyarrhythmia symptoms resembling WPW syndrome (palpitations, dizziness) appear first because of an accompanying accessory pathway.
The physical signs and test findings of corrected transposition of the great arteries vary with associated anomalies, ventricular function, and atrioventricular conduction abnormalities.
Physical examination findings: because the aorta is located anteriorly and to the left at the upper left sternal border, aortic pulsation may be palpable at the upper left sternal border. In the simple form, auscultatory findings may be normal or mild, but with an associated VSD a systolic murmur is heard at the lower left sternal border, and with associated PS a systolic ejection murmur is heard. With severe tricuspid regurgitation, a pansystolic murmur is heard at the lower left sternal border, and with severe regurgitation it radiates from the lower left sternal border toward the right. Cyanosis is absent in the simple form but appears with a large VSD + severe PS.
ECG findings: the ECG pattern specific to ccTGA is relatively characteristic and serves as a diagnostic clue. Characteristically, Q waves are observed in the right precordial leads (V1, V2) and absent in the left precordial leads (V5, V6) (a pattern opposite to normal). This is because the morphologic right ventricle is located on the left, reversing the direction of ventricular depolarization. Abnormalities of the ventricular depolarization axis (left or right axis deviation) are common. First-degree atrioventricular block (prolonged PR interval) is a common finding, and complete right bundle branch block (RBBB) or left bundle branch block (LBBB) patterns are also observed. When complete atrioventricular block occurs, atrioventricular dissociation appears.
Chest X-ray findings: the upper left heart border is straightened (straightened left heart border) because the morphologic aorta is located anteriorly on the left. Cardiomegaly appears when ventricular dysfunction and tricuspid regurgitation have progressed. Pulmonary vascular markings increase or decrease depending on the size of the associated VSD and the pulmonary artery pressure.
Echocardiographic findings: confirming atrioventricular discordance and ventriculoarterial discordance is key. It is confirmed that the morphologic right ventricle is connected to the left atrium through the tricuspid valve, not the mitral valve (morphologic mitral valve). Morphological identification is possible using the characteristics of the morphologic right ventricle: coarse trabeculations and the presence of a moderator band. With systemic right ventricular dysfunction, reduced TAPSE, reduced right ventricular fractional area change (FAC), and reduced EF on 3D right ventricular volumetric measurement appear.
Cardiac MRI findings: superior to echocardiography for quantifying the volume, ejection fraction, and myocardial fibrosis (late gadolinium enhancement, LGE) of the systemic right ventricle. The severity of tricuspid regurgitation (regurgitant fraction) can be measured precisely. A right ventricular EF < 40–45% is used as a criterion for clinical intervention for ventricular dysfunction.
Screening for corrected transposition of the great arteries is done mainly through prenatal fetal echocardiography and neonatal critical congenital heart disease (CCHD) screening. Because the simple form is difficult to detect in the neonatal period and diagnosis may be delayed into adulthood, clinical awareness to include ccTGA in the differential diagnosis when ECG abnormalities or atrioventricular block are found in adult cardiology clinics is important.
Prenatal fetal echocardiography: detailed fetal echocardiography performed at 18–22 weeks of pregnancy is the primary screening tool for ccTGA. On the four-chamber view, a mirror image in which the morphologic right ventricle is on the left and the left ventricle on the right may be observed. On the outflow tract view, the 'parallel great arteries' finding, in which the two vessels run in parallel without crossing, is confirmed. However, the simple form may be difficult to detect on fetal echocardiography, so review by an experienced fetal cardiologist is needed.
Neonatal CCHD screening: when associated anomalies are present, abnormalities are detected on oxygen saturation screening (pulse oximetry), leading to confirmation by echocardiography. In the simple form, oxygen saturation is normal, so it is not detected by CCHD screening.
Incidental discovery in adulthood: when absent or reversed Q waves in the right precordial leads, atrioventricular block, or ventricular conduction abnormalities are found on an ECG performed at a health checkup or for other reasons, echocardiography is performed to evaluate for ccTGA. Straightening of the upper left heart border on chest X-ray is also a clue. In adult patients (especially young adults) with complete atrioventricular block of unknown cause, ccTGA is an important differential diagnosis, so echocardiography is essential.
With a family history: the risk of congenital heart disease recurrence in siblings and children of ccTGA patients is increased by about 1–3%, so detailed fetal echocardiography is recommended during pregnancy. When heterotaxy or situs inversus is present, related genetic testing and consultation with a pediatric pulmonologist (PCD evaluation) are considered.
Confirmation of corrected transposition of the great arteries is a process of fully defining the atrial-ventricular-great artery connections through segmental analysis of the heart and comprehensively evaluating associated anomalies and ventricular function.
Transthoracic echocardiography (TTE): the basic and core test for diagnosing ccTGA. Segmental analysis confirms atrial situs (situs solitus/inversus), morphological identification of the ventricles (morphologic left ventricle: fine trabeculations, fibrous continuity of the bileaflet atrioventricular valve; morphologic right ventricle: coarse trabeculations, moderator band, insertion of the trileaflet tricuspid valve lower toward the apex), and great artery connections and spatial relationships. Doppler quantifies the direction and velocity of VSD shunting, the pressure gradient of PS, and the degree of tricuspid regurgitation. Simpson's biplane method, TAPSE, tissue Doppler, and the like are used to assess ventricular function.
Cardiac MRI (CMR): an essential test for long-term follow-up and surgical decisions in ccTGA. 3D volumetric measurement accurately quantifies the end-diastolic volume (EDV), end-systolic volume (ESV), and ejection fraction (EF) of the morphologic right ventricle (systemic ventricle) and morphologic left ventricle (pulmonary ventricle). Late gadolinium enhancement (LGE) assesses myocardial fibrosis. Phase-contrast techniques measure the tricuspid regurgitant fraction and the pulmonary-to-systemic flow ratio (Qp/Qs). T1 mapping can additionally assess diffuse fibrosis.
Cardiac catheterization and angiography: performed when noninvasive tests are insufficient to confirm the anatomy or when preoperative pressure measurement is needed. Measurement of pulmonary artery pressure and pulmonary vascular resistance (PVR) is important for determining surgical indications. Coronary angiography is performed to check for associated coronary artery anomalies and for preoperative evaluation.
Electrophysiology study (EPS): when there are arrhythmia symptoms, it evaluates the exact site and mechanism of atrioventricular conduction abnormalities and checks for an accompanying accessory pathway. 24-hour or long-term Holter monitoring is useful for detecting intermittent atrioventricular block or atrial arrhythmias. When complete atrioventricular block occurs, the need for immediate permanent pacemaker implantation is decided.
Cardiopulmonary exercise testing (CPET): objectively evaluates functional status and surgical timing through peak oxygen consumption (peak VO2) and heart rate response during exercise. Regular CPET (every 2–3 years) is recommended during ACHD follow-up.
Treatment of corrected transposition of the great arteries requires a multidisciplinary approach encompassing correction of associated anomalies, management of systemic right ventricular failure, treatment of atrioventricular block and arrhythmias, and ultimately heart transplantation.
Surgical correction of associated anomalies: a large VSD is corrected by patch closure, and significant PS is relieved with a right ventricle-pulmonary artery conduit (RV-PA conduit) or direct repair. When tricuspid (systemic atrioventricular valve) regurgitation is severe, valve repair or replacement is required. Correction of VSD or PS alone does not solve the fundamental problem of the systemic right ventricle remaining exposed to high pressure.
Anatomic repair: Double Switch Operation: an operation that reconstructs the heart so that the morphologic left ventricle supports the systemic circulation by simultaneously performing an atrial switch (Senning or Mustard) and an arterial switch operation (ASO) or Rastelli operation (when VSD + PS are present). The goal is to prevent long-term systemic right ventricular failure. This operation is performed selectively in childhood (when the morphologic left ventricle is sufficiently developed), and in adults it is considered after ventricular retraining (LV retraining). Surgical risk and long-term outcomes have improved considerably at experienced specialized centers, but it is still debated.
Drug treatment of systemic right ventricular failure: following heart failure management, ACE inhibitors (or ARBs), beta-blockers, mineralocorticoid receptor antagonists (e.g., spironolactone), and diuretics are used. However, some studies indicate that the efficacy of these drugs in systemic right ventricular failure is limited compared with typical left ventricular heart failure, and the evidence base is not yet sufficient. SGLT-2 inhibitors (empagliflozin, etc.) are currently being studied in heart failure accompanying ACHD.
Treatment of atrioventricular block and arrhythmias: when high-grade atrioventricular block (second-degree type 2 or higher) or complete atrioventricular block occurs, permanent pacemaker (PPM) implantation is required. When ventricular function is reduced, a device with cardiac resynchronization therapy (CRT) function is considered. When ventricular dysfunction is severe and there is a risk of sudden death, implantation of a defibrillator (ICD or CRT-D) is reviewed. Atrial fibrillation and atrial flutter are treated with antiarrhythmic drugs (amiodarone, etc.), electrical cardioversion, or catheter ablation.
Heart transplantation: when the disease progresses to end-stage heart failure despite drug treatment and surgical intervention, heart transplantation is the last treatment option. Transplant outcomes in ccTGA patients with ACHD are improving to a level similar to transplantation for typical left ventricular heart failure.
The long-term prognosis of corrected transposition of the great arteries is largely determined by the presence and correction of associated anomalies, systemic right ventricular function, progression of tricuspid regurgitation, occurrence of atrioventricular block, timing of treatment, and center experience.
Survival: the simple form without associated anomalies (isolated ccTGA) has relatively good 20–30-year survival, reported at over 80%. However, when associated anomalies (VSD, PS, tricuspid malformation) are complex, 10-year survival falls to about 60–70%. In patients who successfully undergo the double switch operation, the morphologic left ventricle supports the systemic circulation and long-term prognosis improves, but data on the risk of the operation itself and long-term follow-up are not yet sufficient.
Systemic right ventricular failure: the most important long-term prognostic factor. When the morphologic right ventricular EF falls below 40%, the risks of worsening heart failure symptoms, hospitalization, and death increase. When tricuspid regurgitation worsens concurrently, the volume load on the systemic right ventricle increases and functional decline accelerates. Regular monitoring of right ventricular function with cardiac MRI and early intervention when abnormalities are found are important.
Atrioventricular block and risk of sudden death: the incidence of complete atrioventricular block is about 2% per year, and decades after diagnosis a considerable proportion of patients require a permanent pacemaker. If complete atrioventricular block occurs without a pacemaker, there is a risk of cardiac arrest. In patients with advanced ventricular failure, ICD implantation to prevent sudden death is also considered.
Quality of life and activity: with appropriate management, a relatively normal life is possible for many patients. Monitoring ventricular function and arrhythmias through regular follow-up (cardiac MRI, Holter, exercise testing, serum BNP/NT-proBNP) at a specialized ACHD center is key to improving prognosis. Because the risk of pregnancy increases with ventricular dysfunction or tricuspid regurgitation, the decision is made after multidisciplinary counseling.
Prevention of corrected transposition of the great arteries is divided into primary prevention to prevent occurrence of the congenital malformation itself, and secondary and tertiary prevention to minimize the progression of complications after diagnosis.
Preparing for early management through prenatal diagnosis: when ccTGA is diagnosed on detailed fetal echocardiography at 18–22 weeks of pregnancy, the place of delivery and a neonatal management plan are established before delivery in consultation with a specialized congenital heart disease team. Depending on associated anomalies, immediate surgery or interventional procedures may be required in the neonatal period.
Regular follow-up and early intervention: lifelong regular follow-up at a specialized ACHD center is essential for ccTGA patients. In childhood, the timing and method of surgery to correct associated anomalies are decided with an experienced pediatric cardiac surgery team. From adulthood, echocardiography, ECG, and BNP tests are performed 1–2 times a year, and cardiac MRI and exercise testing every 2–3 years. When declining systemic right ventricular function is detected early, the multidisciplinary team reviews starting drug treatment and whether surgical reintervention is needed.
Pacemaker and ICD management: even before complete atrioventricular block occurs, prophylactic pacemaker implantation is considered when there is second-degree atrioventricular block or ventricular dysfunction. For implanted pacemakers or ICDs, device function is checked regularly and lead status is inspected.
Pregnancy and contraception counseling: in female patients, ventricular function and tricuspid regurgitation are evaluated before pregnancy, and pregnancy risk is counseled according to the WHO pregnancy risk classification. Pregnancy is not recommended when ventricular EF is significantly reduced. Guidance on safe contraceptive methods (progestin-only oral contraceptives, intrauterine devices, etc.) is needed.
Graham TP Jr, Bhatt AB, Celermajer DS, et al. Diagnosis and management of adults with congenital heart disease. J Am Coll Cardiol. 2008;52(23):1881-1971. DOI: 10.1016/j.jacc.2008.10.001. PMID: 19038677.
Warnes CA, Williams RG, Bashore TM, et al. ACC/AHA 2008 guidelines for the management of adults with congenital heart disease. J Am Coll Cardiol. 2008;52(23):e143-e263. DOI: 10.1016/j.jacc.2008.10.001. PMID: 19038677.
Van Praagh R. What is congenitally corrected transposition? N Engl J Med. 1998;339(25):1842-1844. DOI: 10.1056/NEJM199812173392511. PMID: 9854122.
Prieto LR, Hordof AJ, Secic M, et al. Progressive tricuspid valve disease in patients with congenitally corrected transposition of the great arteries. Circulation. 1998;98(10):997-1005. DOI: 10.1161/01.CIR.98.10.997. PMID: 9737519.
Hraska V, Duncan BW, Mayer JE Jr, et al. Long-term outcome of surgically treated patients with corrected transposition of the great arteries. J Thorac Cardiovasc Surg. 2005;129(1):182-191. DOI: 10.1016/j.jtcvs.2004.07.010. PMID: 15632841.
Beauchesne LM, Warnes CA, Connolly HM, et al. Outcome of the unoperated adult who presents with congenitally corrected transposition of the great arteries. J Am Coll Cardiol. 2002;40(2):285-290. DOI: 10.1016/S0735-1097(02)01952-6. PMID: 12106934.
Presbitero P, Somerville J, Rabajoli F, et al. Corrected transposition of the great arteries without associated defects in adult patients: clinical profile and follow up. Br Heart J. 1995;74(1):57-59. DOI: 10.1136/hrt.74.1.57. PMID: 7662469.
Stout KK, Daniels CJ, Aboulhosn JA, et al. 2018 AHA/ACC Guideline for the Management of Adults With Congenital Heart Disease. J Am Coll Cardiol. 2019;73(12):e81-e192. DOI: 10.1016/j.jacc.2018.08.1029. PMID: 30121239.
Hechter SJ, Fredriksen PM, Liu P, et al. Angiotensin-converting enzyme inhibitors in adults after the Mustard procedure. Am J Cardiol. 2001;87(5):660-663. DOI: 10.1016/S0002-9149(00)01476-8. PMID: 11249901.
Wallis GA, Debich-Spicer D, Anderson RH. Congenitally corrected transposition. Orphanet J Rare Dis. 2011;6:22. DOI: 10.1186/1750-1172-6-22. PMID: 21527012.